Only Snake Curaremimetic Toxins with a Fifth Disulfide Bond Have High Affinity for the Neuronal α7 Nicotinic Receptor*

Long chain and short chain curaremimetic toxins from snakes possess 66–74 residues with five disulfide bonds and 60–62 residues with four disulfide bonds, respectively. Despite their structural differences all of these toxins bind with high affinity to the peripheral nicotinic acetylcholine receptors (AChR). Binding experiments have now revealed that long chain toxins only, like the neuronal κ-bungarotoxin, have a high affinity for a chimeric form of the neuronal α7 receptor, with K d values ranging from about 1 to 12 nm. In contrast, all other toxins bind to the chimeric α7 receptor with a low affinity, withK d values ranging between 3 and 22 μm. These results are supported by electrophysiological recordings on both the wild-type and chimeric α7 receptors. Amino acid sequence analyses have suggested that high affinities for the neuronal receptor are associated with the presence of the fifth disulfide at the tip of the toxin second loop. In agreement with this conclusion, we show that a long chain toxin whose fifth disulfide is reduced and then dithiopyridylated has a low affinity (K d = 12 μm) for the neuronal α7 receptor, whereas it retains a high affinity (K d = 0.35 nm) for the peripheral AChR. Thus, a long chain curaremimetic toxin having a reduced fifth disulfide bond behaves like a short chain toxin toward both the peripheral and neuronal AChR. Therefore, functional classification of toxins that bind to AChRs should probably be done by considering their activities on both peripheral and neuronal receptors.

[1]  R M Stroud,et al.  The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor. , 1986, Protein engineering.

[2]  E. Hawrot,et al.  NMR solution structure of an alpha-bungarotoxin/nicotinic receptor peptide complex. , 1993, Biochemistry.

[3]  A. Maelicke,et al.  The sites of neurotoxicity in alpha-cobratoxin. , 1983, The Journal of biological chemistry.

[4]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[5]  E. Albuquerque,et al.  The Use of Snake Toxins for the Study of the Acetylcholine Receptor and its Ion-Conductance Modulator , 1979 .

[6]  D. Bertrand,et al.  Electrophysiology of Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes following Nuclear Injection of Genes or cDNAs , 1991 .

[7]  M. Lane,et al.  Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Petsko,et al.  Three-dimensional structure of neurotoxin a from venom of the Philippines sea snake. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Shimada,et al.  Acetylcholine receptors of human skeletal muscle: a species difference detected by snake neurotoxins , 1985, Brain Research.

[10]  P. Corfield,et al.  Erabutoxin b. Structure/function relationships following initial protein refinement at 0.140-nm resolution. , 1986, European journal of biochemistry.

[11]  J. Changeux,et al.  Tritium labelling of the α-neurotoxin of Naja nigricollis , 1971 .

[12]  J P Changeux,et al.  Binding of Naja nigricollis (3H)alpha-toxin to membrane fragments from Electrophorus and Torpedo electric organs. I. Binding of the tritiated alpha-neurotoxin in the absence of effector. , 1974, Molecular pharmacology.

[13]  A. Harvey,et al.  Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. , 1994, Trends in pharmacological sciences.

[14]  G. Lunt,et al.  Methyllycaconitine: a selective probe for neuronal α‐bungarotoxin binding sites , 1990 .

[15]  R Anand,et al.  Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. , 1994, Molecular pharmacology.

[16]  E. Bennett,et al.  Radiolabeled alpha-bungarotoxin derivatives: kinetic interaction with nicotinic acetylcholine receptors. , 1981, Biochemistry.

[17]  B. Martin,et al.  Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle. , 1996, Biochemistry.

[18]  J. Changeux,et al.  Identification of a New Component of the Agonist Binding Site of the Nicotinic 7 Homooligomeric Receptor (*) , 1995, The Journal of Biological Chemistry.

[19]  A. Ménez,et al.  Genetic Engineering of Snake Toxins , 1995, The Journal of Biological Chemistry.

[20]  J. Changeux,et al.  Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.

[21]  S. Zinn-Justin,et al.  Genetic engineering of snake toxins. Role of invariant residues in the structural and functional properties of a curaremimetic toxin, as probed by site-directed mutagenesis. , 1993, The Journal of biological chemistry.

[22]  D. Bertrand,et al.  Pharmacology and Biophysical Properties of α7 and α7 ‐ α8 α‐Bungarotoxin Receptor Subtypes Immunopurified from the Chick Optic Lobe , 1994 .

[23]  S. Zinn-Justin,et al.  High-level production and isotope labeling of snake neurotoxins, disulfide-rich proteins. , 1997, Protein expression and purification.

[24]  R. Loring,et al.  Amino acid sequence of toxin F, a snake venom toxin that blocks neuronal nicotinic receptors , 1986, Brain Research.

[25]  L. Pillet,et al.  A recombinant snake neurotoxin generated by chemical cleavage of a hybrid protein recovers full biological properties , 1990, FEBS letters.

[26]  E. Hawrot,et al.  Functional expression and site-directed mutagenesis of a synthetic gene for alpha-bungarotoxin. , 1994, The Journal of biological chemistry.

[27]  D. Bertrand,et al.  A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX , 1990, Neuron.

[28]  C. Roumestand,et al.  Three-dimensional solution structure of a curaremimetic toxin from Naja nigricollis venom: a proton NMR and molecular modeling study. , 1992, Biochemistry.

[29]  C. Y. Lee Chemistry and pharmacology of polypeptide toxins in snake venoms. , 1972, Annual review of pharmacology.

[30]  E X Albuquerque,et al.  Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. , 1992, Molecular pharmacology.

[31]  A. Maelicke,et al.  Three-dimensional structure of the "long" neurotoxin from cobra venom. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  V. Chiappinelli,et al.  κ-Bungarotoxin: binding of a neuronal nicotinic receptor antagonist to chick optic lobe and skeletal muscle , 1988, Brain Research.

[33]  A. Ménez,et al.  Structure of snake toxins and their affinity to the acetylcholine receptor of fish electric organ. , 1977, Toxicon : official journal of the International Society on Toxinology.